In SSRI withdrawal, brain zaps go from overlooked symptom to center stage (2023)

Original Article ↗ Hacker News Discussion ↗

Overall range of experiences with SSRIs/SNRIs

  • Many report SSRIs/SNRIs as life‑saving: reduced severe depression/anxiety, allowed normal functioning, “gave life back,” often with minimal ongoing side effects.
  • Others describe profound negatives: emotional numbing, loss of motivation/creativity, cognitive fog, memory issues, sexual dysfunction, sleep problems, and feeling “like a zombie.”
  • Responses are highly individual: same drug can be a “godsend” for one person and disastrous or ineffective for another.

What brain zaps feel like

  • Commonly described as brief electric shocks or “degaussing” in the head; like hitting the funny bone, teeth-whitening zaps, or a YouTube video buffering in the brain.
  • Often triggered or worsened by eye or head movement, or peripheral visual motion; some report a momentary loss of train of thought or “skipped second” of life.
  • Typically occur during withdrawal or missed doses of SSRIs/SNRIs, but some report similar sensations with MDMA, other psych meds, long Covid, panic disorder, or even lifelong without drugs.
  • Severity ranges from mildly annoying to debilitating, sometimes lasting weeks to months; a few fear long‑term or permanent changes.

Withdrawal and tapering

  • Many accounts of severe withdrawal from sertraline, venlafaxine (Effexor), duloxetine (Cymbalta), paroxetine (Paxil), etc., even with planned tapers.
  • Strategies include very slow dose reductions over many months, bead-counting from capsules, microgram scales, and cross‑tapering to long half‑life drugs like fluoxetine (Prozac).
  • Some report comparatively easy discontinuation with minimal or no brain zaps; variability is emphasized.
  • Several warn that abrupt cessation can trigger extreme mood swings, suicidality, or intense physical symptoms.

Critiques of psychiatry and pharma

  • Posters highlight earlier professional dismissal of brain zaps and discontinuation effects, seeing it as tied to marketing SSRIs as “non‑addictive.”
  • Some argue psychiatric drugs do far more harm than good and call for drastic reduction or even future legal reckoning.
  • Others strongly counter that, despite flaws and overprescribing, SSRIs are among few effective tools for serious depression/anxiety.

Alternatives and adjuncts

  • Mentioned options: bupropion (with both highly positive and severely adverse experiences), TMS, ketamine, SAM‑e, psychotherapy/CBT, exercise, light, sleep hygiene, social connection, psychedelics, and acupuncture.
  • General caution: do not stop or change psychiatric meds without a careful, medically supervised plan.